» Articles » PMID: 37441703

Association Between Extremely High-density Lipoprotein Cholesterol and Adverse Cardiovascular Outcomes: a Systematic Review and Meta-analysis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The association between high-density lipoprotein cholesterol (HDL-C) and adverse cardiovascular outcomes is understudied. Based on cohort studies, the current study aimed to investigate the association of extremely high HDL-C with all-cause, atherosclerotic cardiovascular disease (CVD) mortality, and stroke risk.

Methods: A systematic literature search in Embase, PubMed, Cochrane Library, and Web of Science was performed to collect relevant cohort studies published before August 20, 2022. A random-effects model was used to pool relative risks (RRs) and 95% confidence intervals (CIs).

Results: A total of 17 cohort studies involving 19,630,829 participants were included, encompassing 18,547,132 total deaths (1,328,036 CVD deaths). All-cause mortality, CVD mortality, and stroke risk in the extremely high HDL-C group were increased by 15% (RR = 1.15, 95% CI:1.05-1.25), 14% (RR = 1.14, 95% CI:0.96-1.35) and 14% (RR = 1.14, 95% CI:0.82-1.58), compared to the normal HDL-C group. In subgroup analyses, extremely high HDL-C was associated with a reduced risk of CVD mortality in women and a lower risk of stroke in men compared to normal HDL-C levels.

Conclusions: The extremely high levels of HDL-C were associated with elevated risks of all-cause mortality, CVD mortality, and stroke. More well-designed studies are needed to confirm our findings.

Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=370201, identifier: CRD42022370201.

Citing Articles

Gene-Diet Interactions in High-Density Lipoprotein Cholesterol-Related Polymorphisms and Cardiovascular Disease Risk: Insights from the Korean Genome and Epidemiology Study.

Lee J, Hong K, Park B, Choi J, Jung D Nutrients. 2025; 17(5).

PMID: 40077648 PMC: 11902253. DOI: 10.3390/nu17050778.


Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events.

Santos T, Pereira Q, Fortunato I, Oliveira F, Alvarez M, Ribeiro M Nutrients. 2024; 16(21).

PMID: 39519454 PMC: 11547493. DOI: 10.3390/nu16213621.


The triglyceride glucose: high-density lipoprotein cholesterol ratio is associated with coronary artery calcification evaluated via non-gated chest CT.

Tong Y, Wang Y, Chen X, Qin B, Liu Y, Cui Y Cardiovasc Diabetol. 2024; 23(1):376.

PMID: 39449019 PMC: 11515353. DOI: 10.1186/s12933-024-02464-z.


The Correlation between Elevated HDL-Cholesterol, Body Mass Index, and Presence of Thyroid Nodules: A Retrospective Analysis.

Zorkun C, Yalta K, Eren A, Yetkin E J Clin Med. 2023; 12(23).

PMID: 38068463 PMC: 10707360. DOI: 10.3390/jcm12237411.

References
1.
Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed M, Al-Aly Z . High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans. Clin J Am Soc Nephrol. 2016; 11(10):1784-1793. PMC: 5053782. DOI: 10.2215/CJN.00730116. View

2.
Umeki Y, Adachi H, Enomoto M, Fukami A, Nakamura S, Nohara Y . Serum Albumin and Cerebro-cardiovascular Mortality During a 15-year Study in a Community-based Cohort in Tanushimaru, a Cohort of the Seven Countries Study. Intern Med. 2016; 55(20):2917-2925. PMC: 5109556. DOI: 10.2169/internalmedicine.55.6931. View

3.
Liu C, Dhindsa D, Almuwaqqat Z, Sun Y, Quyyumi A . Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality. Am J Cardiol. 2022; 167:43-53. DOI: 10.1016/j.amjcard.2021.11.041. View

4.
Ko D, Alter D, Guo H, Koh M, Lau G, Austin P . High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study. J Am Coll Cardiol. 2016; 68(19):2073-2083. DOI: 10.1016/j.jacc.2016.08.038. View

5.
Woodward M, Barzi F, Feigin V, Gu D, Huxley R, Nakamura K . Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. Eur Heart J. 2007; 28(21):2653-60. DOI: 10.1093/eurheartj/ehm427. View